About IPRI
Our People
Our Research
Get Involved
Dr Kerry Gilmore
|
Qualifications: Research interests: My interest in the process of cell death (apoptosis) was initiated during my PhD at the University of Wollongong. This flowed naturally into the post-doctoral research that I did at the University of Notre Dame in South Bend, Indiana, USA on the mechanisms of action of the breast cancer drug, tamoxifen. My current work is based around designing and testing new conducting and/or biodegradable substrates for tissue engineering applications. As well as producing conducting and composite materials for my particular projects, materials and structures that are produced by other members of the Bionics group at IPRI are tested for cytotoxicity and for suitability as substrates for cell adhesion, proliferation and differentiation. The cell types that we are investigating include both primary and transformed variants of muscle, neural, fibroblastic and endothelial cells. The cell work encompasses a range of techniques, including cell culture, immunohistochemistry, biochemical assays, fluorescence staining and imaging and SEM whilst preparation of the materials utilises electrochemical techniques, goniometry, conductivity measurement, RAMAN scattering and SEM. Key Publications:
Memberships: ASBTE (Australian Society for Biomaterials and Tissue Engineering)
email: kerryg@uow.edu.au |
Figure 3: Confocal micrograph of Calcein-stained L929 fibroblast cells on 0.05% SWNT in SIBS films
Figure 4: Epifluorescence image of Calcein stained C2C12 muscle cells on electrospun fibres made from a polythiophene.
|
IPRI Noticeboard

9-11 June 2010: Nanobionics Symposium, UOW Innovation Campus, Wollongong
2010 July 4-9: International Conference on Science and Technology of Synthetic Metals 2010 (ICSM 2010), Kyoto, Japan







